Search Results - "Canes, J."

Anti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study by Prat, A., Adamo, B., Perez Fidalgo, J.A., Blanch, S., Martinez, N., Gomez Pardo, P., López González, A., Murillo Juso, L., Amillano, K., Vidal, M., Pascual, T., Pare, L., Canes, J., Galvan, P., Gonzalez Farre, B., Ortega Cebrian, V., Gonzalez, X., Bellet Ezquerra, M., Villagrasa, P., Ciruelos, E.M.

Get full text

Primary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study) by Pernas, S., Villagrasa, P., Vivancos, A., Scaltriti, M., Rodon, J., Burgues, O., Nuciforo, P.G., Canes, J., Dueñas, M., Vidal, M., Lluch, A., Perelló, A., Llombart, A., Dorca, J., Montaño, Á, Oliveira, M., Ribas, G., Rapado, I., Prat, A., Ciruelos, E.M.

Get full text

Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment? by Cejalvo, Juan Miguel, Falato, Claudette, Villanueva, Lorea, Tolosa, Pablo, González, Xavier, Pascal, Mariona, Canes, Jordi, Gavilá, Joaquín, Manso, Luis, Pascual, Tomás, Prat, Aleix, Salvador, Fernando

“…•The goal of immunotherapy in cancer is to overcome immunosuppression induced by the tumour and its microenvironment, thereby allowing the immune system to…”
Get full text

Abstract P5-11-04: Anti-proliferative effect of oral metronomic vinorelbine (mVNB) in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): A randomized, three-arm, window-of-opportunity study by Prat, A, Adamo, B, Pascual, T, Perez Fidalgo, JA, Blanch, S, Martínez, N, Gomez Pardo, P, Lopez Gonzalez, A, Murillo Jaso, L, Amillano, K, Vidal, M, Paré, L, Canes, J, Galvan, P, Gonzalez Farre, B, Ortega Cebrián, V, Gonzalez, X, Bellet Ezquerra, M, Villagrasa, P, Ciruelos, E

“…Abstract BACKGROUND: The anti-proliferative effect of mVNB alone or in combination with endocrine therapy in patients with hormone receptor-positive/HER2-…”
Get full text

Abstract PD3-03: SOLTI-1303 PATRICIA phase II trial (STAGE 1) -- Palbociclib and trastuzumab in postmenopausal patients with HER2-positive metastatic breast cancer by Ciruelos, E, Villagrasa, P, Paré, L, Oliveira, M, Pernas, S, Cortés, J, Soberino, J, Adamo, B, Vazquez, S, Martínez, N, Perelló, A, Bermejo, B, Martínez, E, Garau, I, Melé, M, Morales, S, Galván, P, Pascual, T, Canes, J, Nuciforo, P, Gonzalez, X, Prat, A

“…Abstract Background: CDK4/6 inhibition combined with anti-HER2 therapy is currently being explored in HER2-positive (HER2+) BC. Here, we report the efficacy,…”
Get full text

Abstract P6-18-02: Primary and secondary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study) by Pernas, S, Villagrasa, P, Nuciforo, PG, Vivancos, A, Scaltriti, M, Rodón, J, Burgués, O, Canes, J, Dueñas, M, Cecchi, F, Vidal, M, Lluch, A, Perelló, A, Llombart, A, Dorca, J, Montaño, A, Oliveira, M, Ribas, G, Rapado, I, Paré, L, Prat, A, Ciruelos, E

“…Abstract Background: Metastatic breast cancer is the second leading cause of death among women globally. A better understanding of tumor biology, and the…”
Get full text

VENTANA (SOLTI-1501): Antiproliferative effect of the addition of oral metronomic vinorelbine to endocrine therapy in luminal/HER2-negative early breast cancer: A window of opportunity trial by Adamo, B., Perez Fidalgo, J.A., Ciruelos, E., Vidal, M., Blanch, S., Lopez, A., Gomez Pardo, P., Murillo, L., Amillano, K., Martínez Jañez, N., Gonzalez, X., Canes, J., Prat, A.

Get full text

199PAnti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study by Prat, A, Adamo, B, Perez Fidalgo, J A, Blanch, S, Martinez, N, Gomez Pardo, P, López González, A, Murillo Juso, L, Amillano, K, Vidal, M, Pascual, T, Pare, L, Canes, J, Galvan, P, Gonzalez Farre, B, Ortega Cebrian, V, Gonzalez, X, Bellet Ezquerra, M, Villagrasa, P, Ciruelos, E M

Get full text

284OPrimary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study) by Pernas, S, Villagrasa, P, Vivancos, A, Scaltriti, M, Rodon, J, Burgues, O, Nuciforo, P G, Canes, J, Dueñas, M, Vidal, M, Lluch, A, Perelló, A, Llombart, A, Dorca, J, Montaño, Á, Oliveira, M, Ribas, G, Rapado, I, Prat, A, Ciruelos, E M

Get full text

199P Adoptive PD1+ tumor-infiltrating lymphocyte therapy for metastatic TNBC: First results of the safety run-in phase of the TILS001 clinical trial by Angelats, L., Eslava, M. Santisteban, Manich, C. Saura, Ciruelos, E.M., González-Navarro, E.A., Alvarez-Vallina, L., Lasarte, J.J., Gros, A., Vizcay, Á.M., Oliveira, M., Ortega, P. Tolosa, Rego, M. Español, Brasó-Maristany, F., Galván, P., Chic, N., Villanueva, L., Ruiz, J. Canes, Juan, M., Pascual, T., Prat, A.

Get full text

Abstract P2-09-04: Association of intrinsic subtype and immune genes with pathological complete response in the OPTIHER-HEART phase II clinical trial following neoadjuvant trastuzumab/pertuzumab-based chemotherapy in HER2-positive breast cancer by Gavila, J, Oliveira, M, Pascual, T, Pérez, J, Canes, J, González, X, Paré, L, Calvo, I, Ciruelos, E, Muñoz, M, Virizuela, JA, Ruiz, I, Andrés, R, Perelló, A, Martínez, J, Morales, S, Marín, M, Martínez, D, Quero, JC, Llombart-Cussac, A, Prat, A

“…Abstract Background. In HER2-positive early breast cancer, neoadjuvant therapy based on dual HER2 blockade with trastuzumab and pertuzumab in combination with…”
Get full text

AGATA molecular screening program: Implementing precision medicine in patients with advanced breast cancer in Spain by Pernas Simon, S., Villagrasa Gonzalez, P., Vivancos, A., Prat, A., Scaltriti, M., Burgues, O., Rodon, J., Canes, J., Lluch, A., Llombart, A., Dorca, J., Perelló Martorell, A., Oliveira, M., Montaño, A., Garcia-Estevez, L., Nuciforo, P., Ribas, G., Rapado, I., de la Pena, L., Ciruelos, E.

Get full text

Why Has US Policy Uncertainty Risen Since 1960? by Baker, Scott R., Bloom, Nicholas, Canes-Wrone, Brandice, Davis, Steven J., Rodden, Jonathan

“…We consider two classes of explanations for the rise in policy-related economic uncertainty in the United States since 1960. The first stresses growth in…”
Get full text

Following in Her Footsteps? Faculty Gender Composition and Women's Choices of College Majors by Canes, Brandice J., Rosen, Harvey S.

“…Although it is widely supposed that a college's female undergraduate enrollment in the sciences and engineering can be increased by raising female…”
Get full text

Following in Her Footsteps? Faculty Gender Composition and Women's Choices of College Majors by Canes, Brandice J., Rosen, Harvey S.

Get full text

Following in her footsteps? Faculty gender composition and w by Canes, Brandice J, Rosen, Harvey S

“…Although it is widely supposed that a college's female undergraduate enrollment in the sciences and engineering can be increased by raising female…”
Get full text

Following in her footsteps? Women's choices of college majors and faculty gender composition by Canes, Brandice J, Rosen, Harvey

“…Although it is widely supposed that a college's female undergraduate enrollment in the sciences and engineering can be increased by raising female…”
Get full text

The year 2001: In search of the obelisk by Canes, Patrick J.

Get full text

Role models in education by Ehrenberg, Ronald G

“…There are many policies to increase the number of under-represented minorities in faculty positions in American colleges, universities, and elementary and…”
Get full text